Tamarack Advisers as of June 30, 2019
Portfolio Holdings for Tamarack Advisers
Tamarack Advisers holds 21 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allscripts Healthcare Solutions (MDRX) | 13.9 | $46M | 3.9M | 11.65 | |
| Medtronic | 12.5 | $41M | 420k | 98.02 | |
| Bio-Rad Laboratories (BIO) | 9.4 | $31M | 100k | 309.31 | |
| Pacira Pharmaceuticals (PCRX) | 8.2 | $27M | 625k | 43.27 | |
| Stericycle (SRCL) | 6.8 | $22M | 475k | 47.10 | |
| AtriCure (ATRC) | 6.5 | $21M | 675k | 31.40 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 6.1 | $20M | 730k | 27.54 | |
| Quest Diagnostics Incorporated (DGX) | 5.9 | $19M | 189k | 102.47 | |
| Portola Pharmaceuticals | 4.4 | $14M | 555k | 25.98 | |
| Rigel Pharmaceuticals | 4.3 | $14M | 5.5M | 2.56 | |
| Hologic (HOLX) | 4.0 | $13M | 275k | 47.34 | |
| Haemonetics Corporation (HAE) | 3.7 | $12M | 100k | 120.57 | |
| Zimmer Holdings (ZBH) | 3.3 | $11M | 90k | 120.70 | |
| Novocure Ltd call | 2.9 | $9.6M | 150k | 64.24 | |
| Cantel Medical | 2.8 | $9.1M | 115k | 79.24 | |
| Correvio Pharma Corp | 2.3 | $7.4M | 3.4M | 2.22 | |
| Iveric Bio | 1.1 | $3.7M | 3.0M | 1.24 | |
| Streamline Health Solutions (STRM) | 1.0 | $3.3M | 2.1M | 1.56 | |
| Nevro (NVRO) | 1.0 | $3.2M | 50k | 63.08 | |
| Spdr S&p 500 Etf Tr option | 0.0 | $48k | 4.0k | 12.00 | |
| Amgen Inc option | 0.0 | $11k | 250.00 | 44.00 |
